Clinical trial

Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study

NCT02642029

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Excitatory TMS Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Inhibitory TMS Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Sham TMS Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-18

PhaseNA

Conditions

Schizophreniaverified · MONDO: schizophrenia

Schizoaffective Disorderverified · MONDO: schizoaffective disorder

Bipolar Disorder Iunresolved

Interventions

Excitatory TMSDEVICE

Inhibitory TMSDEVICE

Sham TMSDEVICE

Sponsors & collaborators

Mclean Hospitallead sponsor

Massachusetts General Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02642029 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.